SecBot SecBot
PRESS-RELEASE ·Filed Jun 2, 2026

TLX

Telix Pharmaceuticals Limited
NEUTRAL
Impact 4/10
Horizonmonths Processed5mo ago WireGlobeNewswire
Press release · Contract
Actionable Insight • Neutral

This is a non-binding exploratory MOU with no financial terms, unlikely to move the stock near-term. The key catalyst for TLX remains the PDUFA date of September 11, 2026 for TLX101-Px. Monitor for any subsequent definitive agreements or expansion announcements.

DirectionNeutral
Confidencemedium
Horizonmonths

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$9.16
T+0 close · Jun 2, 2026 · via day close
Latest settled
+21.51%
T+60 · $11.13
Vs SPY
+20.39%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 2 $9.16entry
  2. T+1 · 6mo ago −4.26%α −3.54% · $8.77
  3. T+5 · 5mo ago +2.73%α +5.69% · $9.41
  4. T+20 · 5mo ago +29.26%α +30.82% · $11.84
  5. T+60 · 3mo ago +21.51%α +20.39% · $11.13

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Telix Pharmaceuticals and United Imaging signed an MOU to evaluate a strategic research collaboration integrating Telix's radiopharmaceuticals with United Imaging's scanner platforms, initially focusing on TLX101-Px (Pixclara) in the U.S. The collaboration is exploratory and non-binding, with no financial terms disclosed, and does not change Telix's near-term revenue or regulatory trajectory.

Key Facts

  • MOU signed with United Imaging Healthcare North America to evaluate integrated theranostics workflows.
  • Initial focus on TLX101-Px (Pixclara, Floretyrosine F 18) in the U.S., with potential expansion to other products and markets.
  • TLX101-Px NDA accepted by FDA in April 2026, with PDUFA goal date of September 11, 2026.
  • No financial terms, revenue commitments, or binding obligations disclosed.
  • Collaboration includes scanning protocol optimization, workflow tools, and pilot programs.

Financial Impact

No financial terms disclosed; collaboration is exploratory and non-binding.

Risk Factors

  • MOU is non-binding and may not lead to a definitive agreement.
  • TLX101-Px has not received marketing authorization in any jurisdiction; FDA decision pending.
  • No revenue or cost-sharing details provided; financial impact uncertain.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3304988

Track record

27 reports on TLX

Performance horizon

10 of 21 bullish or bearish reports moved the stock their way by T+1. Best: +29.26% at T+20 after the Jun 1, 2026 report. 19 of 21 went positive at some point.

Filters
  1. Oct 29, 202618d ago 6-K Neutral 5/10 Entry $9.10 to $9.05 Now $8.92 −1.98% ▼ −0.55% −0.07% vs SPY
  2. Oct 20, 202627d ago 6-K Neutral 4/10 No price data
  3. Oct 20, 202627d ago Press Release Bullish 6/10 Entry $10.03 to $9.54 Now $8.92 −11.07% ▼ −4.89% −3.70% vs SPY
  4. Sep 29, 20266w ago 6-K Bullish 6/10 Entry $10.97 to $10.72 Now $8.92 −18.69% ▼ −2.28% −2.46% vs SPY
  5. Sep 21, 20268w ago 6-K Bullish 7/10 Entry $11.31 to $11.95 Now $8.92 −21.13% ▲ +5.66% +5.67% vs SPY
  6. Sep 20, 20268w ago Press Release Bullish 7/10 Entry $11.31 to $11.95 Now $8.92 −21.13% ▲ +5.66% +5.67% vs SPY
  7. Sep 14, 20269w ago 6-K Bullish 8/10 Entry $12.83 to $11.83 Now $8.92 −30.48% ▼ −7.79% −7.35% vs SPY
  8. Sep 14, 20269w ago Press Release Bullish 8/10 Entry $11.78 to $12.83 Now $8.92 −24.28% ▲ +8.91% +9.37% vs SPY
  9. Sep 1, 202610w ago 6-K Bullish 7/10 Entry $11.45 to $11.74 Now $8.92 −22.10% ▲ +2.53% +1.49% vs SPY
  10. Sep 1, 202610w ago Press Release Bullish 6/10 Entry $11.45 to $11.74 Now $8.92 −22.10% ▲ +2.53% +1.49% vs SPY
Showing 10 of 27

US Market Status

Market Closed · Opens Wed (10h 17m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 2, 2026